Literature DB >> 28299625

The effects of lipoic acid on redox status in brain regions and systemic circulation in streptozotocin-induced sporadic Alzheimer's disease model.

Mehmet Evren Erdoğan1, Seval Aydın1, Karolin Yanar1, Murat Mengi2, Ahmet Doğukan Kansu3, Tamer Cebe3, Ahmet Belce4, Mert Çelikten5, Ufuk Çakatay6.   

Abstract

While the deterioration of insulin-glucose metabolism (IGM), impaired redox homeostasis (IRH), β-amyloid accumulation was reported in Sporadic Alzheimer's Disease (SAD) model, aforementioned factors related to lipoic acid administration and anthropometric indexes (AIs) are not yet studied with integrative approach. β-amyloid accumulation, redox homeostasis biomarkers and AIs are investigated in SAD model. Streptozotocin-induced inhibition of insulin-signaling cascade but not GLUT-2 and GLUT-3 transporters takes a role in β-amyloid accumulation. Inhibition types are related to IRH in cortex, hippocampus and systemic circulation. Lipoic acid (LA) shows both antioxidant and prooxidant effect according to the anatomical location. LA administration also leads to improved AIs during GLUT-2 inhibition and cortical redox status in GLUT-3 inhibited group. Optimal LA action could be possible if its redox behavior is balanced to antioxidant effect. Diagnostic usage of systemic IRH parameters as biomarkers and their possible correlations with deteriorated IGM should be investigated. Graphical abstract ᅟ.

Entities:  

Keywords:  Anthropometric indexes; Insulin-glucose metabolism; Lipoic acid; Oxidative stress; Sporadic Alzheimer’s disease model; β-amyloid accumulation

Mesh:

Substances:

Year:  2017        PMID: 28299625     DOI: 10.1007/s11011-017-9983-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  47 in total

1.  Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway.

Authors:  Melita Salkovic-Petrisic; Florian Tribl; Manuela Schmidt; Siegfried Hoyer; Peter Riederer
Journal:  J Neurochem       Date:  2006-01-12       Impact factor: 5.372

2.  Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.

Authors:  E Sofic; M Salkovic-Petrisic; I Tahirovic; A Sapcanin; S Mandel; M Youdim; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2014-09-25       Impact factor: 3.575

3.  Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.

Authors:  Esma Altunoglu; Gulcan Guntas; Fusun Erdenen; Esen Akkaya; Ibrahim Topac; Hulya Irmak; Himmet Derici; Hakan Yavuzer; Remise Gelisgen; Hafize Uzun
Journal:  Geriatr Gerontol Int       Date:  2014-10-27       Impact factor: 2.730

4.  A simple method for clinical assay of superoxide dismutase.

Authors:  Y Sun; L W Oberley; Y Li
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

5.  Oxidative damage to proteins: spectrophotometric method for carbonyl assay.

Authors:  A Z Reznick; L Packer
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  Ascorbic acid-dependent GLUT3 inhibition is a critical step for switching neuronal metabolism.

Authors:  Felipe A Beltrán; Aníbal I Acuña; María Paz Miró; Constanza Angulo; Ilona I Concha; Maite A Castro
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

7.  Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain--an immunohistochemical study.

Authors:  Michel Arluison; Monique Quignon; Philippe Nguyen; Bernard Thorens; Corinne Leloup; Luc Penicaud
Journal:  J Chem Neuroanat       Date:  2004-11       Impact factor: 3.052

Review 8.  Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.

Authors:  Siegfried Hoyer
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

9.  Streptozotocin induced Alzheimer's disease like changes and the underlying neural degeneration and regeneration mechanism.

Authors:  Pradip Kumar Kamat
Journal:  Neural Regen Res       Date:  2015-07       Impact factor: 5.135

10.  Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer's disease.

Authors:  Harsh Sancheti; Garnik Akopian; Fei Yin; Roberta D Brinton; John P Walsh; Enrique Cadenas
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

View more
  4 in total

1.  5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease.

Authors:  Nasrin Hashemi-Firouzi; Siamak Shahidi; Sara Soleimani-Asl; Alireza Komaki
Journal:  Metab Brain Dis       Date:  2018-04-17       Impact factor: 3.584

2.  Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.

Authors:  Noorul Hasan; Saima Zameer; Abul Kalam Najmi; Suhel Parvez; Mohd Akhtar
Journal:  Neurotox Res       Date:  2022-02-22       Impact factor: 3.911

3.  Exercise renovates H2S and Nrf2-related antioxidant pathways to suppress apoptosis in the natural ageing process of male rat cortex.

Authors:  Jing-Ying Lin; Tsung-Jung Ho; Bruce Chi-Kang Tsai; Chien-Yi Chiang; Hui-Chuan Kao; Wei-Wen Kuo; Ray-Jade Chen; Vijaya Padma Viswanadha; Chi-Wen Huang; Chih-Yang Huang
Journal:  Biogerontology       Date:  2021-07-12       Impact factor: 4.277

4.  Caloric restriction improves the redox homeostasis in the aging male rat heart even when started in middle-adulthood and when the body weight is stable.

Authors:  B Simsek; K Yanar; A D Kansu; A Belce; S Aydin; U Çakatay
Journal:  Biogerontology       Date:  2018-10-29       Impact factor: 4.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.